Tag: Prescription Drugs
Hydroxychloroquine No Use for COVID Postexposure Prophylaxis
Post-high-risk-exposure prophylaxis does not prevent illness compatible with COVID-19
COVID-19 Drug Studies Questioned
Journals issue 'expressions of concern' over two recent studies of medications and their effect on COVID-19 patients
Reducing Number of BP Meds May Be Safe in Some Older Adults
No significant change in systolic BP control seen at 12 weeks versus pretrial medication
Benzodiazepine Use Linked to Risk for Ectopic Pregnancy
Excess of 80 ectopic pregnancies per 10,000 pregnancies found in women with benzodiazepine prescription
One-Third of Lupus Patients Have Trouble Refilling Hydroxychloroquine
Patients report lack of availability at usual pharmacy, waiting weeks for refills, only getting partial refills
ACE Inhibitors, ARBs Not Linked to In-Hospital COVID-19 Death
Risk for in-hospital death increased with age >65, underlying cardiovascular disease, COPD, smoking
Hydroxychloroquine Plus Macrolides No Benefit in COVID-19
Hydroxychloroquine, chloroquine with or without macrolides linked to in-hospital mortality, arrhythmia
Guideline Details Pharmacologic Management of COPD
Clinical practice guideline addresses six emerging questions around COPD management
Long-Term Rituximab May Aid in Antibody-Associated Vasculitis
Relapse rates lower versus placebo in granulomatosis with polyangiitis, microscopic polyangiitis
Hydroxychloroquine Prescriptions Surge in U.S. During Pandemic
Increase in hydroxychloroquine/chloroquine fills seen during week of March 15 to 21, 2020
